Changes in Condom Use During the First Year of HIV Treatment in Uganda and the Relationship to Depression

Published in: Annals of Behavioral Medicine, v. 48, no. 2, Oct. 2014, p. 175-183

Posted on RAND.org on January 01, 2014

by Glenn Wagner, Bonnie Ghosh-Dastidar, Mary Ellen Slaughter, Dickens Akena, Noeline Nakasujja, Seggane Musisi

PURPOSE: We examined the effect of antiretroviral therapy (ART), and the predictive role of depression, on condom use with primary partners. METHODS: Data from three studies in Uganda were combined into a sample of 750 patients with a primary sex partner, with 502 starting ART and 248 entering HIV care, and followed for 12 months. Random-effects logistic regression models were used to examine the impact of ART, and the influence of baseline level and change in depression, on condom use with primary partners. RESULTS: At month 12, 61% ART and 67% non-ART patients were consistent condom users, compared to 44 and 41% at baseline, respectively. Multivariate analysis revealed that consistent condom use increased similarly for ART and non-ART patients, and that minor depression at baseline and increased depression over time predicted inconsistent condom use. CONCLUSIONS: Improved depression diagnosis and treatment could benefit HIV prevention.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.